Charles River Laboratories Hits New 52-Week High of $236.92

Charles River Laboratories International, Inc. has reached a significant milestone by hitting a new 52-week high of USD 236.92 on July 10, 2026. This achievement underscores the company's performance within the miscellaneous industry, where it operates as a small-cap entity with a market capitalization of USD 7,858 million. Over the past year, Charles River Laboratories has demonstrated a performance increase of 8.81%, although this is notably lower than the S&P 500's performance of 20.62% during the same period. The company's price-to-earnings (P/E) ratio stands at 26.00, indicating its valuation relative to earnings. Additionally, the firm maintains a debt-to-equity ratio of 0.62, reflecting a moderate level of leverage. With a return on equity of 9.58% and a price-to-book ratio of 2.48, Charles River Laboratories continues to navigate its market position effectively. The stock's previous 52-week low was recorded at USD 144.26, highlighting the significant upward movement in its price.